ResearcherUniversity of California, San FranciscoActive in the last 2 years
Lisa Miller‐Phillips
Matched on ORCID iD 0009-0000-5368-4205; OpenAlex author ID A5007414735. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Co-author DOI 10.1038/s41586-025-09017-8↗
- Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches. Co-author DOI 10.1158/2159-8290.cd-23-1480↗
- RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming. Co-author DOI 10.1007/s11864-023-01096-x↗
- Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 stu… Co-author DOI 10.1016/j.esmoop.2022.100388↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eric Andrew Collisson · 2 shared papers, 2023–2025 · strength 0.57
- Michael Haas · 3 shared papers, 2022–2025 · strength 0.48
- Paper Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches. DOI 10.1158/2159-8290.cd-23-1480↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the… DOI 10.1016/j.esmoop.2022.100388↗
- Steffen Ormanns · 3 shared papers, 2022–2025 · strength 0.48
- Paper Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches. DOI 10.1158/2159-8290.cd-23-1480↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the… DOI 10.1016/j.esmoop.2022.100388↗
- Volker Heinemann · 3 shared papers, 2022–2025 · strength 0.48
- Paper Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches. DOI 10.1158/2159-8290.cd-23-1480↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the… DOI 10.1016/j.esmoop.2022.100388↗
- Stefan Hubert Boeck · 3 shared papers, 2022–2025 · strength 0.48
- Paper Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches. DOI 10.1158/2159-8290.cd-23-1480↗
- Paper PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. DOI 10.1038/s41586-025-09017-8↗
- Paper Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the… DOI 10.1016/j.esmoop.2022.100388↗
- Jen Jen Yeh · 2 shared papers, 2025 · strength 0.37
- Stephan Krüger · 2 shared papers, 2022–2025 · strength 0.29
- Alina Cornelia Iuga · 1 shared paper, 2025 · strength 0.19
- Gary L. Johnson · 1 shared paper, 2025 · strength 0.19
- Naim U. Rashid · 1 shared paper, 2025 · strength 0.19
- Shawn M. Gomez · 1 shared paper, 2025 · strength 0.19
- Yi Xu · 1 shared paper, 2025 · strength 0.19
- Roberto Zoncu · 1 shared paper, 2025 · strength 0.18
- Michael Guenther · 1 shared paper, 2025 · strength 0.18
- Gilles Rademaker · 1 shared paper, 2025 · strength 0.18
- Grace Kim · 1 shared paper, 2025 · strength 0.18
- Rushika Miriam Perera · 1 shared paper, 2025 · strength 0.18
- Annalena Abendroth · 1 shared paper, 2022 · strength 0.11
- Andreas Wolfgang Berger · 1 shared paper, 2022 · strength 0.11
- Volker Kunzmann · 1 shared paper, 2022 · strength 0.11
- Oliver Waidmann · 1 shared paper, 2022 · strength 0.11
- Sebastian Kobold · 1 shared paper, 2022 · strength 0.11
- Marianne Sinn · 1 shared paper, 2022 · strength 0.11
- Thomas Jens Ettrich · 1 shared paper, 2022 · strength 0.11
- Thomas Theodor Werner Seufferlein · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.